word,tfidf
disease,1.9196697118781982
week,1.7180728337038118
day,1.5866106057633769
graft,1.5736489871587067
transplantation,1.472480240628017
cell,1.431044516597033
host,1.401104893703297
versus,1.348735514189613
uveitis,1.2894621135029887
stem,1.2084463121343858
cells,1.1275514408246108
haplo,1.0392390907012115
days,1.0372239850300506
bd,1.0300116125989014
12,1.0247961668103671
transplant,0.9875158573711735
hematopoietic,0.9338151123473493
mesenchymal,0.9284204746906453
others,0.8818989356029165
stromal,0.8816176103073061
anti,0.8800937410432087
non,0.8474937781894979
prevalence,0.8120698656331298
response,0.7830610092485748
donor,0.7724246194042003
antibiotic,0.7594608198200543
survival,0.7453381124895186
relapse,0.7410206559640772
weeks,0.727363559057862
randomized,0.7270049609710918
refractory,0.7234408411154107
dose,0.7130547407784149
milligrams,0.7110549885478358
severe,0.7077348963399841
blood,0.7070448277306411
subjects,0.7048009061232907
prior,0.693154725642253
kilograms,0.6814837837861282
post,0.6799755725537904
within,0.6717159914365955
cd,0.6679095878045074
active,0.6663775820054045
efficacy,0.6601881273382533
acute,0.6405407514939914
human,0.6387889599135317
duration,0.6384947182475207
conditioning,0.6376696791730178
therapy,0.632490460485964
vasculitis,0.6270882223666496
related,0.617368087711207
first,0.6140412223041453
one,0.6036414127964377
sct,0.5992232990304953
rate,0.5990194067976402
ks,0.5967839700278836
arm,0.5857678506969729
systemic,0.577650108556972
pharmacodynamic,0.5768865941196112
defined,0.5729850716477838
24,0.5617746360137945
adalimumab,0.5545623713434824
according,0.5524859871481133
overall,0.5523837452700318
graall,0.5471018513416509
period,0.5446772808587284
infection,0.5441369294250947
allogeneic,0.5440060190059202
increased,0.5399773122216012
covid,0.5353766390015947
including,0.531749708548484
treated,0.5273554318618354
ptcy,0.5255725240288996
concentration,0.5227145007847612
placebo,0.5210068568318891
use,0.5168667926638746
19,0.515634238698058
leukocyte,0.5139623485805942
injection,0.5125428547507326
activity,0.5101977388895687
matched,0.5088917240141649
antigen,0.5066498643427825
safety,0.5047191941843397
imaging,0.4991434771148535
oral,0.4957942533970057
drug,0.4950810333949764
14,0.494704187634249
hospital,0.4933354049372238
new,0.48999905457069337
using,0.4878233416362767
breast,0.48365205537315825
group,0.4804390560298676
grade,0.47805167504353246
16,0.4761946692781957
90,0.47554559663299184
life,0.47374428605336205
evaluate,0.47179117897330924
effects,0.46842333319427265
adverse,0.46828332970771747
stage,0.46786803443536296
two,0.4678219097975614
hospitalization,0.4673532075085655
care,0.46683888978402777
cyclophosphamide,0.4620250329234651
per,0.4614601159290639
tumor,0.4609919040695073
negative,0.4603448718459264
high,0.4583866601170317
unrelated,0.4578554448046851
following,0.4542807589803292
48,0.4516630371625996
infusion,0.45010369708721104
reported,0.447384915058549
least,0.44618352426987284
year,0.4458052083472869
regimen,0.4441270387179246
research,0.4433687303439716
results,0.4396769156313525
rituximab,0.4358362453701335
also,0.43570639277365886
belimumab,0.43446549676809476
free,0.43346735326063657
21,0.43283407034076066
events,0.43274398660017227
randomization,0.4317062093711519
prednisone,0.42790802325509025
tocilizumab,0.4274603783249583
complete,0.42674150334005395
score,0.42613197576235856
aes,0.42406465712058977
mud,0.42385373757190525
endpoint,0.4229624206951567
chronic,0.4227387008009696
20,0.42141848543449884
tnf,0.41828164823821057
data,0.41742628554309275
failure,0.4119844622212511
side,0.4116819230415776
15,0.40619073969060965
remission,0.4055579081983091
incidence,0.40473533133378575
best,0.40299129404351136
fludarabine,0.4021781895222154
used,0.3994717257106939
treosulfan,0.39856042726616325
mortality,0.39699223126667804
immune,0.39597692880625923
without,0.3950846847212785
marrow,0.39446686818060595
hydrogen,0.39194752749606915
ion,0.39194752749606915
visit,0.39187301878837094
effect,0.38825848758706816
intravenous,0.38816660283266724
pediatric,0.3877325293042064
anemia,0.38056393745251355
ii,0.38003346370438934
hours,0.3791350536568227
cancer,0.3784107419241283
involvement,0.3753605407359396
identical,0.3730911436777936
associated,0.37305597733994855
quality,0.37189079701779887
eye,0.36833195821964315
22,0.3637174568490275
lesions,0.36192385137449484
administration,0.3616074522234335
history,0.3612403814105106
ocular,0.35982987363240154
50,0.3595070072346988
performed,0.3592097780777847
may,0.3584826470201078
40,0.3569678740239603
saa,0.35612050180680355
compared,0.35358077054252934
specific,0.3527394236179167
retinal,0.35202587190517326
antibodies,0.35105799695870127
standard,0.3483955989420622
thymoglobulin,0.3460200477971543
function,0.3447342916153288
36,0.34457729858875114
pembrolizumab,0.3436709617895648
test,0.3435653555285278
major,0.342915510600963
main,0.3421981199429502
leukemia,0.3419149790248386
virus,0.34013227927061174
based,0.3399822269256763
prophylaxis,0.3391398513479053
evidence,0.3378086535940539
behcets,0.3377872865266138
25,0.33715377231527577
immunosuppressive,0.336278768957952
adult,0.33477867779404785
infectious,0.33447276275533544
due,0.33413516728813075
intensive,0.33228440708571017
corticosteroids,0.33143457711601093
mycophenolate,0.32940275187051643
last,0.3265388175226582
decreased,0.32632765643487194
tuberculosis,0.3246276946304643
time,0.3239001779873103
conventional,0.3216472864796159
profile,0.31823553886531275
effective,0.31687630078290535
extension,0.3151342619426872
obtained,0.31512720833927693
2005,0.31244131065068836
participants,0.3122377165023917
classic,0.3121393310651799
endemic,0.3121393310651799
risks,0.3113891823101466
endpoints,0.31090954169940577
management,0.3108298164994421
of,0.3105659260345553
aplastic,0.31043534916924387
groups,0.3102258818641064
monoclonal,0.30805925816714413
mofetil,0.30747026544457595
baseline,0.30735543239807406
age,0.30602999778866397
drugs,0.3056016884972075
system,0.30540387133582503
observed,0.30530472097946454
28,0.30275987029094864
available,0.3022540500541806
responders,0.30127106714148366
assessment,0.30109403681418845
60,0.29963497453399246
infections,0.2996008363133604
compare,0.2992648975119237
informed,0.2991373940463668
ml,0.29864471213060384
treatments,0.29830843152850156
ultrasound,0.2961075940779134
approach,0.29587741501278964
unit,0.2948745166438857
visual,0.29407572664230486
protocol,0.29367571050835406
skin,0.2930083656257195
70,0.29261309819900266
complications,0.2921631011309544
centers,0.28948063398772705
syndrome,0.28783157462924575
sample,0.28778475551429067
center,0.2867769750544391
louis,0.28611549202861913
every,0.28282005214747546
event,0.28254979883950343
term,0.2822498761240036
classification,0.28214766686226644
prospective,0.282086562449248
investigational,0.28199627989425646
renal,0.28153754839018075
mismatch,0.2803519367510995
cutaneous,0.27884857976147165
saint,0.2786565006677292
trials,0.27709574646658536
reduced,0.2764664051630702
2003,0.275785331057885
inflammation,0.27568609293268503
levels,0.2744322869556682
reduction,0.2741789676047925
thus,0.27297425437844186
assess,0.27295654710737827
l1,0.27142444794789655
serum,0.2713877979089631
daily,0.2711402621380181
minimal,0.2705759392808654
received,0.2700584166429048
biomarkers,0.269647394689225
respiratory,0.2691667736672619
simons,0.26871125786184163
toxicity,0.2667173034473869
comparing,0.2666613376402764
lung,0.26641061602354776
niu,0.26554751258006654
cellular,0.26521388825759795
long,0.2650377878408977
therapeutic,0.2650229373370774
recently,0.26436866332771375
cases,0.2641856955447869
potential,0.26415184049188795
nausea,0.26409020979891457
health,0.2639543409033515
organ,0.26322246401609595
100,0.2625803659919383
records,0.2619916637098866
optimal,0.26196373995823447
assessed,0.26119755155349456
resistant,0.26059017284870856
additional,0.26051246106558135
80,0.2600301168778276
interventional,0.2596331703480372
haploidentical,0.2596249207572643
sepsis,0.25859313169709136
inspired,0.258465101963681
sclerosis,0.2573338159050418
national,0.25722769872489226
current,0.2571810402218242
antibody,0.2570915405139365
case,0.2568244827098988
subject,0.25644523151541854
women,0.2561618190099527
size,0.25574335274624277
red,0.2556669424154314
sarcoma,0.25509062292089946
agent,0.2545838163276434
progression,0.2545258428651124
macular,0.25389897870502726
irradiation,0.2538257722887693
fatigue,0.25362633171392
2019,0.252686865207242
ap,0.2526778400543427
methods,0.2526252571094759
rates,0.25226715027952323
biological,0.2521748168320832
tolerance,0.2519653730229129
injected,0.2517763089761262
resonance,0.251678225803384
magnetic,0.251678225803384
met,0.2516675301095632
corticosteroid,0.2516176970817229
05,0.2502069007487435
gene,0.2493085852084651
monitoring,0.24905649723409057
therapies,0.2478261701818562
site,0.24651361634128077
13,0.24583267219738908
requiring,0.2455502055013842
cure,0.24533429294173464
experimental,0.24416319850525392
confirmed,0.24332242248334784
11,0.24300666712050778
ist,0.2429854936530137
pain,0.24237644744214348
carcinoma,0.24236992584764017
creatinine,0.2419595807881728
cardiac,0.24195056628729486
less,0.24182689155959322
observational,0.24160936776863876
45,0.24150771361286374
55,0.2414940679217035
bone,0.24145958453336105
poor,0.23971293192313226
pcr,0.2396795229536649
benefit,0.23934493507301496
peripheral,0.23877916740424515
known,0.2387278854700684
positive,0.23854221062515624
hp,0.23828632281708964
death,0.23791759665895837
infliximab,0.2378412079333364
acuity,0.23772072828720525
arms,0.23771587039946732
digital,0.23769251878448816
common,0.23750359042541974
changes,0.23684660336208874
either,0.23667383687832058
lupus,0.23617712149350417
scientific,0.2343521499743364
central,0.23427717126844866
french,0.23419795415752342
ratio,0.23346507912594736
aged,0.23319448746551968
sites,0.2328916564221042
adults,0.23147207024447367
signs,0.23086665030029047
line,0.23022011263005843
pulmonary,0.2302043775876229
previous,0.23016216240447793
must,0.2298583497466177
tomography,0.22860082785671298
tumors,0.22840697036501711
inhibitor,0.22721497493782755
occurrence,0.22718249496960083
recherche,0.2266624098354475
busulfan,0.22634564760942855
106,0.22616824915825673
engraftment,0.22587325692421753
however,0.22546726688396168
donors,0.2254201565726897
threatening,0.22472833287828303
transfusion,0.2243642352264686
multicenter,0.22394024936192986
heart,0.22380317452690118
regardless,0.22344934628909774
considered,0.22341899994301728
rash,0.22333806546308707
ciprofloxacin,0.22307049829804448
level,0.22269526809725762
statistical,0.22251976387310585
count,0.22241841458282258
urinary,0.22170590433986462
viral,0.22156290944886856
increase,0.22121116946897507
agents,0.22107885175498504
posterior,0.22106512793947908
similar,0.22029690975766542
include,0.21938639306086216
inflammatory,0.2191144833423375
suspected,0.21900750539748592
receiving,0.21899555998303222
control,0.21862097338742986
disorders,0.21849730899991118
end,0.21662540783066633
terms,0.21642247202477197
transfusions,0.21630736750709373
partial,0.21596061627141158
philadelphia,0.2151129919999542
multi,0.21495600274964077
abnormalities,0.21467984593452386
full,0.21467636187968803
kidney,0.2146424717847604
vascular,0.214576046319895
intestinal,0.21457077826141494
outcomes,0.21430511906319866
sparing,0.21400206347039763
aminotransferase,0.21389483772050624
nomenclature,0.2138114361474374
pregnant,0.21339469247505896
product,0.21289348171449138
outcome,0.2128613078901728
higher,0.2120543170215119
sensitivity,0.21182750513016368
demonstrated,0.21174038257807606
contraception,0.21106445175368485
acquired,0.21028249392395812
old,0.21025918706403132
absence,0.20997114121646931
status,0.2096989204342347
combination,0.20951783478796593
selection,0.20928682878702015
immunodeficiency,0.20832892101411848
option,0.20814302636669899
showed,0.208083301204266
35,0.2076309229125195
change,0.20704658110873675
clinique,0.20695371939330987
reconstitution,0.20692815342333049
lymphoma,0.20630145147176973
300,0.2062872528611318
melanoma,0.20624991307354573
antibiotics,0.20511526393030494
diagnosis,0.20508981535247772
transplanted,0.2046720749477097
17,0.20418018539413182
standardization,0.20380365953914448
overload,0.2032594661503796
better,0.20316358154054434
steroid,0.20304438752919843
hospitalier,0.20286161533081745
nervous,0.2027530309039177
orally,0.20272134329578248
myeloablative,0.20253527541791305
participation,0.20253180021571418
body,0.20233965082821898
diarrhea,0.20228127309249985
corrected,0.20212498662184003
median,0.202037351162702
different,0.2018649130122689
probability,0.20136376222893945
strategy,0.20125661401042674
uncontrolled,0.20119548704724025
department,0.20078098078943266
evaluation,0.20065621891868715
evaluated,0.20054235884581095
another,0.20042088783976925
adenocarcinoma,0.19946844206731457
complicated,0.19942460308246013
centre,0.198831762801419
france,0.19876720737559472
type,0.19859552797959365
improvement,0.19855257282921063
treat,0.1983869378285165
immunosuppression,0.19831149577920307
oedema,0.19796055118360473
prognosis,0.19700415557141487
three,0.19699243307148973
medical,0.19611252930232262
administered,0.19601968750748697
pre,0.1958619083509951
vomiting,0.19552717856365254
residual,0.19519268937111817
need,0.19506477833225458
programme,0.1950613908235003
fertility,0.1946461483914786
reference,0.19433196801511401
aa,0.19410107784710492
controlled,0.19390822662718712
scale,0.19385543399664648
early,0.1934827729169299
metabolic,0.193278841487799
hepatitis,0.19317851085387655
intensity,0.1930067857234799
justification,0.19286719020675078
present,0.1927410697681467
protein,0.1926470949880908
iron,0.1926173065922296
factors,0.19211495783966723
mscs,0.19203554861719654
source,0.19132356830871336
sibling,0.19095760730736058
clinically,0.19027527722855536
intrauterine,0.19020793563979246
currently,0.1895469414602442
radiation,0.18950740291634594
short,0.18929980185261483
millimeter,0.18853347334986523
induction,0.18819839613390218
international,0.18783343164101887
comparison,0.18648757833873703
significant,0.18571717606777094
iii,0.18554558471240867
pregnancy,0.18512311608727014
diagnostic,0.18507786140057425
chemotherapy,0.18474248427656795
shown,0.18426569476628296
underlying,0.1839238580992712
social,0.18378513283856132
eligible,0.18363372070085893
receive,0.18361069129214402
general,0.18338751803203515
hypersensitivity,0.18321028521390575
contraceptive,0.1830569831909547
four,0.1829968171759944
estimate,0.1829705834064539
followed,0.18242435088718575
thiotepa,0.18187865157665406
injectable,0.18179583933744606
anterior,0.18155918018148204
liver,0.18146729308662782
initial,0.18127709033279363
still,0.18093402152190796
good,0.18078869065468373
bilirubin,0.18011795298064429
presence,0.1800770848432633
aspartate,0.17878056463938302
42,0.1786930468567123
worsening,0.17851013084069564
ci,0.17835422674086612
might,0.17819525839678046
symptoms,0.17793956560292423
dependency,0.17774684403948668
biopsies,0.17702260670191167
subcutaneously,0.17698659224576246
edema,0.17655638254167383
plasma,0.17647984174532008
evolution,0.1759007892833556
samples,0.1758399713059877
signed,0.17583003712543313
several,0.17574590105529625
il,0.1753771023821286
stopped,0.17524560978655185
anakinra,0.17518742450694896
older,0.17516203086389187
children,0.17490342008369023
medicinal,0.1733952317832522
absolute,0.17334851859456119
doses,0.1724488704326833
despite,0.17225648005976765
independent,0.17222871600396972
exclusion,0.1721512660779666
role,0.17210404886726186
required,0.1719383003651266
second,0.171886711575318
lymphoblastic,0.1717608820362274
cd20,0.1716792764939908
pr,0.17141819031818245
method,0.17135377967032342
female,0.17117486679419458
acronym,0.1709703129506064
tract,0.17061595419526887
single,0.17058110889698397
procedure,0.17055951125774316
equivalent,0.17031038811357124
since,0.1700219723480692
promising,0.1697994087995
device,0.16962801240332226
2016,0.16878675104660204
5mg,0.16860834890129567
manifestations,0.1683975111696
globulin,0.16824799455183637
proportion,0.16778019386979592
persistent,0.16754424247575644
association,0.1673168269128691
2012,0.16709034680985724
coherence,0.1670293961955843
transferase,0.16604673634369313
amino,0.16604673634369313
funding,0.16528621691280046
steroids,0.16446067625749866
appendix,0.1644168001372471
alanine,0.16413893699469753
immunomodulatory,0.16411600361569162
twice,0.16405554170881667
responses,0.16375670129486422
autoimmune,0.16364360806799955
grfs,0.16355251541782062
replacement,0.16348809599366923
benefits,0.1632440067727112
emergency,0.16320653257987938
abstinence,0.162974638026084
reduce,0.16294516933626585
dysfunction,0.16277668967139253
board,0.16275506257624395
date,0.16252317180908096
95,0.16244098338504753
initiation,0.16231748716712477
value,0.16222020192979406
asthenia,0.16212622388437856
correlation,0.1617665545310584
vs,0.16171433644928904
cubic,0.16168860824271458
chimerism,0.1616196828816286
exposed,0.16149766218331382
would,0.1612951689115219
psychiatric,0.16119006110088635
head,0.1604523962641138
mmhg,0.16042106172512005
costs,0.16027791596037336
recommended,0.16010032935128696
reaction,0.15986952829119735
impact,0.15956320064457774
could,0.15955143957555268
fraction,0.15911191019828058
given,0.1590828104868094
expression,0.15902812367289115
solution,0.15887439068110695
well,0.1587711837827991
23,0.15837869186648965
usual,0.1583699162302086
planned,0.15803017832523802
mean,0.1574175201422095
past,0.15734184213516825
whether,0.15695795512093136
late,0.15689050892126555
dosage,0.15682080969304313
place,0.1566815209613845
allows,0.15633438139087158
small,0.15592349210347217
advanced,0.1553214263980566
33,0.15531026211897853
individuals,0.15513676095520543
stenosis,0.15475695406498927
continued,0.15474288907082695
umbilical,0.15443623743181287
inferiority,0.15419739238100366
recipient,0.15381220304595453
childbearing,0.153244614426179
low,0.15291366772299733
course,0.1528440486180073
hopital,0.15262664715614166
power,0.15251399526268544
double,0.15251259219572952
mds,0.15134126796706387
cd8,0.15131473188396047
interventions,0.1512561940497247
normal,0.1512510627551935
180,0.15113171981878518
context,0.15082487969805025
resolution,0.15062858668965917
insurance,0.15045962034615595
previously,0.15003439620132175
myeloid,0.14997034474458779
pneumonia,0.14950669654349838
moreover,0.14927755381951371
recent,0.14861361746038004
methotrexate,0.14805782415854904
disorder,0.14785607633523218
respectively,0.14771200770494003
able,0.14738813762781036
sexual,0.14706810834781522
enrolled,0.14691650991912214
legal,0.14623776288249923
lines,0.14612102488271156
highly,0.14604680209876966
cumulative,0.1456776551140522
left,0.14554508672503338
excluded,0.14548743001227982
prevent,0.14528777469931325
for,0.1452343824318181
aims,0.14519188010461054
hormonal,0.14494356708192654
analyses,0.14482661542957642
european,0.1446770357664118
maximum,0.14447100379092911
tissue,0.14438341745501332
multiple,0.14421634305802353
bacteria,0.14409044777436164
neurological,0.14406626886318727
biologic,0.1439784977551111
blinded,0.14366011095833503
participate,0.14329327055289875
derived,0.14285987084711096
described,0.14263900607755106
interferon,0.14260598380505354
involved,0.1424664284134593
reducing,0.14234911961711635
biopsy,0.1419743967136311
security,0.14193318565183113
pathway,0.14192894928942762
vessel,0.1419273935850524
mutations,0.14182417958351937
clearance,0.141724869491942
measures,0.14162787850272274
screening,0.14138959395327322
serious,0.14134920008510635
adaptive,0.1413483829903205
demonstrate,0.14130111596039138
measured,0.1408534241430608
min,0.14084089831331006
written,0.14062231066851724
visits,0.14057108683574746
take,0.14049312702445085
26,0.1404731226696933
shortening,0.14044510358971163
hôpitaux,0.1400138731469175
laboratory,0.13967717286998813
dr,0.13930464201703985
weight,0.13925672806131204
upper,0.13909213397412618
addition,0.13906354400031032
yes,0.13896045713550953
allow,0.13865089672094077
program,0.13852085518236298
institute,0.13833726145263242
improve,0.13811265895730815
ebv,0.1380227320037364
2020,0.13797779844870647
part,0.13790163352247925
injections,0.1378790112858279
terminology,0.13774455611424644
performance,0.13751713643894042
aml,0.1374036752942878
reactions,0.1372672434310766
ric,0.13717025587753373
setting,0.13704551807192766
interest,0.13704117081558054
surgery,0.13699232460098043
2014,0.1369081738773537
see,0.13665917602271294
cervical,0.13645979527948923
80mg,0.13636932439187466
remains,0.13632177666688503
bayesian,0.13595054459934966
carried,0.13562193389865948
medicine,0.13547673280626552
limit,0.1353635183587668
regimens,0.13500279603755255
entry,0.1349288679994283
withdrawal,0.13480567649829164
et,0.1346728112729137
provide,0.1344251234493253
baltimore,0.13410966974402444
published,0.13336311886316637
difference,0.13335457890802888
optical,0.13325271016576837
lariboisiere,0.13308589631356704
anaemia,0.13273920255133664
among,0.13255011938240033
curative,0.1325376055615547
diabetes,0.13251077416660467
sources,0.13244084080098462
intravenously,0.13237405008470482
step,0.1323663329601448
already,0.13224534504183696
retrospective,0.13214114727550152
characteristics,0.1313880803335578
inclusions,0.13122061814269367
cord,0.13081043086034522
products,0.13070006721651817
chest,0.13017277329984892
length,0.12995897878346602
alone,0.12969774396195
pressure,0.12954742902289906
male,0.12934906218287978
severity,0.1291993173185455
200,0.12907117123559228
inactive,0.1290181732736407
schedule,0.1289650186312418
differences,0.12889764293467013
acts,0.12861937186843406
inferior,0.12844408771289775
centres,0.12832749825194503
tablet,0.1282918641007236
hbv,0.12819908308053468
dna,0.1279862541201424
hemoglobin,0.12777829697377913
combined,0.1275535620981793
thymocyte,0.12728725591261067
lymphocytes,0.12725934492604474
biologics,0.12724054110461744
summary,0.12711043522796367
measurement,0.12708714394977344
approved,0.12706874405119223
sided,0.1270507651160368
committee,0.12701766999609118
therefore,0.12690712976158824
found,0.12670192591548463
form,0.12663287517670838
rejection,0.1264861872997834
medication,0.12641587603070414
point,0.1263532743928296
approximately,0.126194245189295
recipients,0.1260930506469975
scope,0.12599402434358223
measure,0.12584029935042892
situation,0.12576775253623648
strong,0.12576653161082238
enrolments,0.12568733696964618
onset,0.12535495161856805
enzyme,0.12503264959569788
interim,0.12497016296754462
forms,0.12494548739522954
tel,0.12491826547992767
indication,0.12489799067933265
characterization,0.12489458580842465
experienced,0.12483635239154406
decrease,0.12475517739369245
occurs,0.12472104174025225
fever,0.12465099835294659
cost,0.12452016277691841
exploratory,0.1244906412150694
immunosuppressants,0.12432801885279901
right,0.1243043658577905
practitioner,0.12422896280337108
missing,0.12422896280337108
breastfeeding,0.12388800334364483
target,0.12376839315274779
give,0.1235899064249709
2018,0.12349550064893272
abnormal,0.12264602137671649
blindness,0.12212925989888411
malignancy,0.12212126856936863
improved,0.12206273740915215
lymphocyte,0.12198632370285495
eligibility,0.12182866961496835
5xuln,0.12154927585415984
partner,0.12150705516064297
development,0.12139855173131975
eyes,0.12125892023786272
practical,0.12113277153714071
103,0.12107761838739277
pneumonitis,0.12097579523259402
stopping,0.12065680824094185
azathioprine,0.12064883139706037
parenteral,0.12055097173065123
detected,0.12037614591475478
error,0.12004277441067876
potentially,0.11977006734508253
procedures,0.11976943090783188
vaccine,0.11936789913716987
alpha,0.11921604134632667
frequent,0.11911523994045847
greater,0.11908847716803297
diseases,0.11908657747867635
young,0.11871845274105672
segment,0.11852888320885083
poorly,0.11846159519293249
adequate,0.11818820772347904
outside,0.1180249198136834
open,0.1180160374504486
lead,0.11798308574491684
pan,0.11778455234503232
unwilling,0.11748410986682248
stay,0.11746438942250095
funded,0.11744774594055811
resistance,0.11734752933752782
cerebral,0.11730156463206635
65,0.11723769754835169
78,0.11717098334232087
multicentre,0.11712318467183999
hematology,0.1170926878433814
vitreous,0.11707445974794636
considering,0.11707200057801904
range,0.11697818782100042
intermediate,0.11664757460678662
mice,0.11656857029003226
cause,0.11651041514295621
team,0.11630135146655317
stratified,0.11628003698449092
necessary,0.11602003378295356
cooperative,0.11583982907177424
hospitalized,0.11568008011371808
cycles,0.11563564773193968
men,0.11559276668010222
moderate,0.11544787319352362
examinations,0.11543131745986683
mainly,0.11537602859021537
like,0.11534623148934427
saadoun,0.11532424144279729
mechanical,0.11508837071244414
ventilation,0.11508837071244414
40mg,0.11483392436596485
hypertension,0.11479920442807999
2017,0.11476453754928168
chamber,0.114667938118926
allo,0.1145865153859425
regarding,0.11430478477266005
physical,0.11422176204506054
tnfa,0.11421156933729283
infected,0.1137432538022691
certain,0.11369889130787117
support,0.11359237249196902
arterial,0.11354505429233548
even,0.1133832814201011
negatively,0.11309480202179774
david,0.11281684682922069
delayed,0.11267084374881547
yet,0.11260803355463166
deciliter,0.11258935582746143
2008,0.11258032531278393
cohort,0.11238836166850887
practice,0.11230364505979264
label,0.11228728353773099
circulating,0.11200543468744162
table,0.11196494374585977
bolus,0.11190884872005584
1mg,0.1116708743789813
genetic,0.1113405683005871
neutrophil,0.11133956871834538
large,0.11112094357979746
diagnosed,0.11098900369916308
immunotherapy,0.11079508396487919
solid,0.11069682783923926
white,0.11061460999236736
action,0.11051423586052797
ventricular,0.1104426270033372
condition,0.11007553612452149
questionnaire,0.10998907552862056
percentage,0.10990429550740827
model,0.10981035589514282
proposed,0.10948018450298018
guidelines,0.10947394656776765
depression,0.10916934974733637
biotherapies,0.1091234564579166
neoplasia,0.10901748777739086
coverage,0.10898831280559489
obstruction,0.10893640534373114
vessels,0.10872703225693753
collection,0.10869642551411965
grafts,0.10863978509478579
hospitalizations,0.10858759366280853
detect,0.10858153529441639
hepatic,0.1084442958323765
comparable,0.10830931031966753
spinal,0.10814444699965728
route,0.10789254356918881
leakage,0.10786087618530564
much,0.10773740165829104
depletion,0.10756184599513449
live,0.10734691428370136
consumption,0.10733732743016187
hhv8,0.10728709881808975
microbiological,0.1069865149662327
rapid,0.10684371651675671
fluid,0.10674402159913138
lack,0.10669049497515398
superior,0.10665477368120162
enroll,0.10646219553830467
la,0.10646218113215303
nicolas,0.1064492325583743
blys,0.10644326936560927
anticipated,0.1063857603738046
2015,0.10637597363985461
2013,0.10622972419577295
platelet,0.10622775808479362
2010,0.10614041410088376
vitro,0.10613912402353409
morbidity,0.10613572872206782
receptor,0.10600884803979296
rationale,0.1058782678668749
direct,0.10585149420397945
neutropenia,0.10575083923520737
sodium,0.10557615140864614
plus,0.10553005046975678
candidate,0.10536885730410571
sf,0.10530702901222802
66,0.10528434852490719
adherence,0.10519526109906108
ig,0.10518147153658938
unable,0.10515239969584522
sub,0.10512620744116705
stable,0.10482412004783756
basis,0.10443379744300134
urine,0.10438924293970155
illness,0.10429766325637072
significantly,0.10398032744853396
developed,0.10385110052516176
needed,0.10380443755230004
induced,0.10362891447424852
none,0.10362000939777036
malignancies,0.10360058159628603
curatorship,0.10355964684040818
excipients,0.10330277434486004
59,0.10289491603798986
recommendations,0.10285147528916533
platelets,0.1027607617894626
fa,0.10273327850756642
dyslipidemia,0.10263675418718671
lesion,0.10242935730085811
resolved,0.1023548840008668
150,0.10231561412860028
abscess,0.10201574733150416
testing,0.10195220342860511
global,0.1019337170828103
54,0.10177630671456905
sectional,0.10176718525715206
oncology,0.10167476869043651
microbiota,0.10166274283356189
osteoporosis,0.1016143211730211
younger,0.10159051390210551
factor,0.10146073580688925
eg,0.10144302086600968
barrier,0.10139513472618653
internal,0.10135679056668222
calculated,0.10130568463056727
needs,0.10124996749032808
relationship,0.10124878088215375
society,0.10122339378293795
haze,0.10089620933012435
vh,0.10086691011713457
determination,0.1008511770208805
definition,0.10076718396269782
report,0.1006759187077671
lower,0.10050049273097048
periods,0.100481427361196
normalization,0.10046906444390404
sampling,0.1004598360986761
recurrent,0.10020795216908476
thoracic,0.10017346791175213
series,0.10013263853443982
01,0.10013077119029304
index,0.09992393925968346
detection,0.09983106794977338
amplification,0.09944261675126863
comparator,0.09926275391781232
director,0.098853023630999
consultation,0.09861473278581864
recruiting,0.09858691175208659
sickle,0.09858691175208659
presented,0.09857063249902812
91,0.09854495426906534
auto,0.0984647656938214
surface,0.09835419668163181
decision,0.09823639296641956
abuse,0.09820037126878359
000,0.09807345306254166
discontinued,0.0980347219635587
inhibition,0.09800825194144813
hemolytic,0.09793088392821869
detecting,0.0978740181523916
proven,0.09782742817198009
31,0.09769603784768413
reading,0.09756017912113644
tested,0.09749059184881279
six,0.09743730456707794
weekly,0.09741722773536238
supportive,0.09740413109285805
dramatically,0.09736722279950974
properties,0.09713916164150391
selected,0.09693286059805506
basal,0.09688174272902278
situ,0.09688174272902278
account,0.09653404756198619
cyclosporine,0.09651254812829659
quantitative,0.09650088257469101
blind,0.09637951050471003
chance,0.09621868668346614
remain,0.0962100661543966
400,0.09609638480657551
hypothesis,0.09601674686053634
interval,0.09573375368711623
grades,0.09569780171533805
joint,0.09551207524162143
substance,0.09551158998215196
intervention,0.09545809956433389
show,0.09534489093864668
pga,0.09529502760551001
affiliation,0.09526810917532087
performans,0.0952379096834212
nih,0.09510028330104803
counts,0.09504525845147299
septic,0.09478169711262191
repeated,0.09473507400360967
investigated,0.09468058197011006
neurologic,0.09467048705732015
require,0.09464962187163181
except,0.09463537983404262
conversely,0.09448487389060549
bmt,0.09409560257788836
centralized,0.09389015176925036
eastern,0.09380337112911136
49,0.09367592471850233
identification,0.09365976910363705
parameters,0.09360575989772932
assuming,0.09323119021197213
mismatched,0.09320104815588469
37,0.0931787828763256
malignant,0.09306587212556588
idiopathic,0.09301928363964357
york,0.09300181404556898
alternative,0.09292796500944256
echocardiography,0.09291142273265508
composite,0.09281406169177217
survive,0.09276842245659062
cognitive,0.09276842245659062
affiliated,0.0927345261848442
extended,0.09267710744921519
parents,0.09253080102485983
reactive,0.09251583638239123
public,0.09247345617379145
experience,0.09229895286249983
examination,0.09227389025775505
rapidly,0.09222540386495579
cerebro,0.09193743428686424
metastatic,0.09192239815707035
cd4,0.0916209881404286
conducted,0.09159040127446583
ecog,0.09150342051738534
question,0.09148341199948527
especially,0.09127640172081514
takes,0.09125360185058533
acceptable,0.09111068699529772
antagonists,0.0910883008854504
people,0.09095376561065335
requires,0.0909351544389852
reasons,0.09092656674685828
prognostic,0.09091477363504079
many,0.09075812277573263
ago,0.09073643753824064
ministry,0.09071139791639486
parallel,0.090622186256283
optimized,0.09053530119491908
delay,0.09034829157901077
five,0.09031757864467088
cross,0.09022660570831742
2000,0.09005803904705678
v3,0.08994520932119748
29,0.08979130540849273
rare,0.08968181835745123
infiltration,0.08961452950867185
adapted,0.08958742716823595
progestogen,0.0895815020622768
participating,0.08956019959771344
cytokines,0.08947523422614342
bilateral,0.0894752149723961
figure,0.0894428504640039
possible,0.08941070215170346
insufficiency,0.08935582209033924
capacity,0.08921433261646354
toxicities,0.08915726294285771
hematological,0.08915714021541182
ag,0.08912909369291984
values,0.08908878763297519
historical,0.08896180539979787
tolerated,0.08894963472852532
cannot,0.08856617482583196
presenting,0.08855874703863038
des,0.08853424082107811
64,0.08829632501361602
500,0.08822430424248777
via,0.08816066317271243
become,0.08807075532968854
prescribed,0.08795552527401906
damage,0.0879439099524969
elderly,0.08786821482271602
prolonged,0.08779358131958065
characterize,0.08771281945961432
52,0.0876857613229816
ct,0.08756107876005179
scores,0.0874762051059454
aim,0.08745764676869354
lineage,0.08744132190088115
fibrosis,0.08735723506324529
often,0.08732595989231794
handle,0.08721318162466223
order,0.08714189068369621
tests,0.08711486060957425
individual,0.08705579552330037
pro,0.08704448574525694
incidences,0.08689223156515181
targeted,0.08685495235997814
develop,0.0867408209509592
squamous,0.08666807565902096
apply,0.08662429429686987
hcv,0.08639845931406213
ovulation,0.08599340427462125
rules,0.0859899643537679
myelodysplastic,0.08582065787674316
infiltrate,0.08572161287859106
5ml,0.08568787494863872
hbs,0.08565117164981913
stop,0.08561950005955776
identify,0.08557490373169502
american,0.08557045407928998
estimated,0.08554733164082651
enrolment,0.08552978995919357
2021,0.08552194308431009
area,0.08540738485174867
allowing,0.08514829399983737
rct,0.08514698172297684
intensification,0.08505666210877384
schemes,0.08505666210877384
invasive,0.0849445490419207
guardianship,0.08481421746217058
outpatient,0.08475830953903438
relative,0.08460258595029865
average,0.08447472262640546
pleural,0.08412074683344548
enzymes,0.08386859254965763
identified,0.08360691565285541
reached,0.08358310493798607
fda,0.08356984052668157
justifying,0.08346991239947779
obtain,0.08343366302734895
cervix,0.08336703281150398
actg,0.08330295639293026
appropriate,0.08321445100819844
alive,0.08320472451243767
clonal,0.08316519341462514
2009,0.08302423335273683
cytopenias,0.0829860475102938
condom,0.08296586728442122
relapses,0.08283932684460882
diameter,0.08279496235673658
potassium,0.08262942887415518
etc,0.08258825479265766
progressive,0.08256558025598176
search,0.08253878179989785
around,0.08239416082070526
responsible,0.08234025166648506
completed,0.08221656974442146
permitted,0.08209835250062769
discontinuation,0.08196227595501325
hemorrhagic,0.08195850448418898
web,0.08192780394629684
coli,0.08191773020264118
professor,0.08181650748509486
intervals,0.08181650748509486
creteil,0.08162954109751172
cytokine,0.08159558821993051
initially,0.08142241105385363
unless,0.08136866983708896
background,0.08129581437403627
observations,0.08128932973064301
deficiency,0.08127740671712017
failed,0.08117218988628128
melphalan,0.08111978570339348
topical,0.08107987929923441
grading,0.08107352592878608
collect,0.08107284952377541
literature,0.08104365669934288
erythematosus,0.08102950483503574
dependent,0.08100669844707738
effusion,0.08096472074028926
tapering,0.08095909336005293
production,0.0805244446182248
gave,0.08042075841883663
recruitment,0.08035509356649399
targets,0.08030633370220028
subcutaneous,0.08028964415644178
phenotypes,0.07994841184763628
significance,0.07975935120962581
extensively,0.0795717196461217
bleeding,0.07932007883065911
safe,0.0791922130261014
limited,0.07918475467668148
state,0.07910534945114198
uc,0.07906060526963563
meeting,0.07903179426092145
led,0.07894447514624488
protection,0.07894079295452655
120,0.07888279721478592
success,0.07880528588880838
gold,0.07869828422828463
cancers,0.07867690646579739
analyzed,0.07861636978999614
computed,0.07841333352922518
pharmacokinetic,0.07822729557625341
205,0.07801589089167951
immunological,0.0779569003893975
glomerular,0.07792949975353958
various,0.07792255404006851
functions,0.0778932953502253
us,0.07776175575299432
prevention,0.07771804871244088
switzerland,0.07769562450393191
authorization,0.0776785090446705
mild,0.07764376053544042
evaluable,0.07763954831021241
working,0.07742819004898668
myelo,0.07739378853807158
ablative,0.07739378853807158
cystitis,0.07729174180150618
bichat,0.07729159125228974
aggravation,0.07729062600195288
innovative,0.07722543243571299
hypothesize,0.07716776181807197
indicated,0.07714635811332422
neutrophils,0.0770995960484399
inform,0.07709878362767159
provides,0.07701381890316983
particular,0.0769261678559181
although,0.07691487538079768
efficient,0.07689725338095438
27,0.0768193777702604
81,0.07666265259646642
directly,0.07661449927599537
conceive,0.07638218081016032
10mg,0.07633389992231347
types,0.07622305118302473
field,0.07618137785076974
log,0.07607580317220726
serology,0.07605715484602661
next,0.07603179397519998
express,0.07603122543014774
alloimmunization,0.0759709969677289
induce,0.07590992868896929
numbers,0.07574021956581513
blaise,0.07573753649533045
allowed,0.0757298016176709
monotherapy,0.07570112920964935
start,0.07543590632875807
focus,0.07532161444007851
tissues,0.07529802256164334
party,0.07524599204436117
taking,0.0752432494710587
fm,0.07508603952948369
pathology,0.07503965011244329
murine,0.07502148542879937
regulatory,0.07500706162661278
volume,0.07487847673925736
whichever,0.07479673401967836
sterilization,0.07470988951877032
infusions,0.07466165093232785
arthritis,0.07455813581612963
glucocorticoids,0.07452327826681962
reactivation,0.07430169614848843
72,0.07429033070791226
fusion,0.07421604359848007
valid,0.07407448860861943
maladies,0.07392355632611623
sustained,0.07376891077908632
developing,0.07357458742927005
toxic,0.07355946290267806
usually,0.07341518994618751
distinct,0.07312131828318813
immunogenicity,0.07305711263198904
consecutive,0.07303211878292244
ray,0.07301438772608988
symptomatic,0.07298299066599595
college,0.07292779146692713
76,0.07278244614555743
du,0.07278107481696323
indeed,0.07274399236042878
multicentric,0.07272128859443952
organs,0.07270342484497891
frequency,0.07265720871484008
magic,0.07245997893649253
consortium,0.07245997893649253
email,0.07231719555240777
chosen,0.07229312065665579
criterion,0.07226621896846544
rt,0.07216866937181912
simple,0.07209900480274287
shock,0.07209900480274287
screened,0.07200151671527444
tablets,0.07200151671527444
systematically,0.07191720156574039
undergoing,0.07187761065560233
excessive,0.07183232103760037
achieve,0.07169872222014213
immunosuppressed,0.07161963286840795
release,0.0713885940760978
prescription,0.0713713509235065
prednisolone,0.07135509378130767
30ml,0.07134015282698077
assessing,0.0713346591346652
complication,0.07121944397091873
ebmt,0.07108009828737069
modified,0.07099895753768529
affect,0.07086155661827423
maintenance,0.07083191290208184
almost,0.0707615803007973
suffering,0.07071992595348986
targeting,0.07070831442109733
sufficient,0.07067225433339067
difficult,0.07060005162509939
specifically,0.07059539650277688
deletions,0.07057358444815784
rearrangements,0.07057358444815784
generation,0.07057358444815784
mutation,0.07057358444815784
transient,0.07021258894507627
million,0.07019408522706545
future,0.07009927634174039
feeding,0.07008607557389224
applicable,0.07003237484276639
recorded,0.06999528602891587
august,0.06991249870581709
lymphopenia,0.06985250490160701
leading,0.06978824613135334
consistent,0.06958844787924989
screen,0.06954122285216802
collaboration,0.06948555669321824
confirm,0.06944435137249261
child,0.06941695466329786
scheme,0.06940685181545181
reproductive,0.0692876313445857
capillary,0.06920418874017623
anxiety,0.06920418874017623
ulcerated,0.06916132512378453
109,0.06912961515141514
compounds,0.0691228408896995
chru,0.0691162004921
profiles,0.06908158353346064
truly,0.06904077935686015
beginning,0.06904077935686015
recovered,0.06904077935686015
bacterial,0.06888254346649227
eventually,0.06887431067745584
define,0.06883561314608572
intent,0.06881756859826811
understanding,0.06881121412656269
healthy,0.06880820735453265
phenotyping,0.06876021295865786
favorable,0.06865510033385351
strategies,0.06863995375448154
na,0.06862892753115085
800,0.06835905756495221
simultaneous,0.06824771081372369
cmu,0.06821170449220916
universal,0.06821170449220916
healthcare,0.06811572090737883
visceral,0.06802111081107608
opportunity,0.06800553930488248
information,0.06797784574592897
specified,0.06782918168036393
salpetriere,0.06771844452254647
pitie,0.06771844452254647
choice,0.0676706209022923
pnh,0.0675644020177577
seems,0.0674532374227577
determine,0.0673744608104601
preceded,0.06736003396167617
exposure,0.06732612477705463
recognition,0.06707852798105607
maintain,0.06707852798105607
apparent,0.06707852798105607
ophthalmology,0.06696208025165704
88,0.06689193203891525
article,0.06686269692644962
microns,0.06684327946254591
projected,0.0667706735333698
chemotherapies,0.0667706735333698
expecting,0.0667706735333698
borr,0.0667706735333698
network,0.06675354215539639
third,0.06673011171086543
sole,0.06657731072833392
discretion,0.066553101095895
humans,0.06650006654125395
recommendation,0.0664116014625558
nk,0.0662925588215252
knowledge,0.06619519056564017
interfere,0.06611828416842817
minimum,0.06610967571094237
transdermal,0.06607917848111644
pao2,0.0660228706835095
matching,0.0660228706835095
mmol,0.0660228706835095
copy,0.0658071644826869
arrest,0.06580249982779568
important,0.06576951538076731
rest,0.06572460783472439
expert,0.06571841405493191
constipation,0.06570433173608814
blocks,0.06567205821958033
concerned,0.0656519144759156
authority,0.0656519144759156
yielded,0.06560335353464672
transaminases,0.06557349390216143
always,0.0655038525001646
requirements,0.06548051513826694
ius,0.06547799522217808
behcet,0.0654598182673916
whose,0.06545821648660609
meet,0.0654149659265515
birth,0.06525107483621326
dependence,0.06515516586599789
confidence,0.0650242132390537
usa,0.06498454942755064
digestive,0.06491913996830645
complement,0.06470308387013678
reduces,0.06444882146733506
improves,0.06444882146733506
suggest,0.06442205292087921
father,0.06435604069250557
recovery,0.06435267197657353
cream,0.06432641373843134
rna,0.06427192669319458
73m2,0.0641901155580404
concomitant,0.0641284858656533
kroger,0.0638567123645
comply,0.06375081810191752
relapsing,0.06373903157571861
frequently,0.06372453214632172
binary,0.06371206512291439
surveillance,0.06367848952893392
died,0.06367803199385469
92,0.06367262259305713
thrombocytopenia,0.06362310077652555
2011,0.06356640979018752
tutorship,0.06350407010057088
debilitating,0.06347013363864375
gives,0.06339517898089773
longer,0.06332844922318585
repair,0.06320226643297307
hypothyroidism,0.06306766941054594
oxygen,0.0630586101100557
162,0.06295500679296614
becoming,0.06294295237940033
willing,0.06292979832539222
fewer,0.06289145745351102
75,0.06283626179218103
june,0.0627649243720243
rank,0.06276403619759824
teams,0.06262845795865157
service,0.062447292904212325
containing,0.06240038886043745
physician,0.06232712731412992
al,0.06230625995921526
vital,0.06230283331883319
consider,0.062290254025778674
immunosuppressant,0.062288246805730065
hypotension,0.06208214868440216
affected,0.06198018831632182
cataract,0.061937172625224295
namely,0.06186138168688652
instability,0.06177028221700863
1000,0.061740132762206454
scan,0.061606185393957694
77,0.06156481214723819
haematopoietic,0.06153661565690079
evaluating,0.06148697728696393
injury,0.061380523756543806
mixed,0.061336861927348246
impaired,0.06131517456715456
chu,0.06108092575506747
nephritis,0.061063540664302085
aimed,0.06101432545191904
cycle,0.06100364671452933
62,0.06092384619198374
variety,0.06078602967208176
involving,0.06077103984514893
ferritin,0.06069669589002887
markers,0.06068816510556362
suggesting,0.0606746656902299
whatever,0.060615183302620265
addressing,0.060607572710958235
mol,0.06057762735530346
bearing,0.06056910574479932
2mg,0.06052985734847688
regression,0.06034419082261203
anticipate,0.06025829186369465
directed,0.06007061509684567
hcg,0.059979368749491405
reaching,0.05995866815437248
investigation,0.05995866815437248
monetary,0.05995866815437248
binding,0.0599536280927508
myeloma,0.05992293998419308
270,0.05988596175705846
extensive,0.059860214495388545
32,0.05977062140460297
conclusion,0.05972593686587509
fulfilling,0.05970087489808289
dosing,0.05955055985373988
02,0.05934966527433502
cs,0.059338476942495985
allergic,0.059332526124703217
chills,0.059327561398525124
done,0.05927782027397797
inference,0.059223232365984174
isolated,0.0592145932542498
little,0.05916191946352812
ejection,0.05913079089607771
earlier,0.05907694330448183
successful,0.05906351831978217
htlv,0.05898356702449895
confirming,0.05896762548394052
34,0.05895330066223502
57,0.05895290136059424
largely,0.05884945916715338
registry,0.05879769870442683
deaths,0.05876573970208286
transmission,0.05876573970208286
preferred,0.0587567081581583
thanks,0.05850701729886952
41,0.05848664071751526
standardized,0.05848477323139905
eltrombopag,0.058473697211751996
registered,0.05831452129293175
permanent,0.05827574308587036
components,0.058138332419082825
harm,0.05810807224400701
informative,0.05810552786224424
formula,0.05800375508600227
sequence,0.05796029787176356
liability,0.05792535720157142
independence,0.057921411421070344
antithymocyte,0.05783701461423599
tubal,0.05782116652760744
superiority,0.057665835672601834
98,0.057662344050326886
pd1,0.057651870670532714
taken,0.05765046656749897
recruited,0.0576142869997969
correlate,0.0576142869997969
particularly,0.05760301253954171
plasmapheresis,0.057590649905656655
person,0.057563939471062066
avoid,0.057541915766040126
starch,0.05745308986526919
progressing,0.057444617273713056
mdrd,0.057444617273713056
ctc,0.05735995013699784
continue,0.05734904997575302
intolerance,0.057304388800079493
deep,0.05715224075003367
collective,0.05714837216545386
project,0.0570698833334934
monthly,0.05676389067484476
unique,0.0567399305901364
called,0.056733504310016086
newly,0.056733504310016086
loss,0.0567078365333757
novo,0.05661465339061457
nephropathy,0.056614548572960964
caused,0.05661001094183479
headache,0.05654586662935602
linked,0.05652448767021366
lives,0.05639598980676826
half,0.05639598980676826
propose,0.05634786990328605
documented,0.05626651022224841
lifestyle,0.05612656869310065
ie,0.05609658345248711
referral,0.055912923645102613
exceed,0.0558935691893449
mobilized,0.05585342074584684
cd34,0.05585342074584684
section,0.05580621521117746
syndromes,0.05578831550790205
initiated,0.05574577098855793
roughly,0.05574577098855793
analyse,0.05573608498980557
successively,0.05573608498980557
rue,0.05573608498980557
hope,0.05573608498980557
rares,0.05559169833710226
systemiques,0.05559169833710226
gastrointestinal,0.055576748366384876
mucocutaneous,0.05552717930916416
tube,0.055450058666773605
cm,0.055450058666773605
decade,0.05544048852746921
appears,0.0554183979353165
randomisation,0.0553150476465667
swelling,0.0552638274821225
admission,0.05519418376331206
sequencing,0.055123280551760634
load,0.055123280551760634
review,0.05509643737530931
controls,0.055090816658708866
immunophenotyping,0.0548672996049133
st,0.0548672996049133
celeste,0.05477860232079006
lebbe,0.05477860232079006
cochin,0.05477860232079006
tolerability,0.05472663236426259
nb,0.05472291242891748
systematic,0.054644401222629375
cough,0.054568493901619726
toulouse,0.05453583319621158
dexamethasone,0.05450625780430912
attenuated,0.054363537412190854
points,0.054312283457320074
sequential,0.05423980261721821
decades,0.054198168561135754
explained,0.05406620733618828
intercourse,0.05405922211187586
world,0.05399341369311656
goal,0.05398290563217701
encouraging,0.05397147673796304
get,0.05395413696231262
rheumatism,0.05391997982142696
league,0.05391997982142696
eu,0.053831588487725686
anaphylactic,0.05382437513481911
estimation,0.05375220229791153
molecules,0.05375220229791153
validated,0.05372065200924005
affecting,0.05369963175871621
modalities,0.0536793944748381
preexisting,0.05362570356077095
filtration,0.05362334420056024
demyelinating,0.05354674872078294
hg,0.05344853010365087
formal,0.05344853010365087
recurrence,0.0534298198413322
willingness,0.0534111246210395
gamma,0.05333420747937787
assumption,0.05325414569777833
leukoencephalopathy,0.053221634682804636
c4,0.053221634682804636
multifocal,0.053221634682804636
inhibitors,0.05315472814882635
commonly,0.053119582185577656
rubi,0.05309279145464031
reviewed,0.053012833542444106
adaptation,0.05299540871429942
shall,0.052980671966441434
states,0.052790672046004496
forced,0.05277610403213974
validate,0.052697814000281
behalf,0.052643623724438385
quick,0.0526354037238772
water,0.05259763054953054
trm,0.0524428147697325
ability,0.052375268053080765
immediate,0.052373718255316205
models,0.05236116161891764
rheumatoid,0.05229303991791062
dyspnea,0.052270464494780386
decided,0.05224681808560137
categorical,0.05224681808560137
conditions,0.05222807506927999
47,0.05220552902151274
sustainable,0.05216355956129366
evaluations,0.05215260265877363
publication,0.05202499093234548
firm,0.05198213489596242
cgy,0.05195834666629034
times,0.051918480691418585
slow,0.05169072280206274
man,0.05163454274019022
determined,0.05161980177608575
issues,0.05158667809420258
1080,0.051537187665345464
225,0.051537187665345464
implemented,0.0514165451853009
confounders,0.05140303729766135
replete,0.051346901526964056
2n,0.051346901526964056
occur,0.05131846797694846
flexibility,0.05125696523611761
offers,0.05125696523611761
simplicity,0.05125696523611761
aplasia,0.05117618098471913
difficulty,0.05117618098471913
europe,0.051173619884220256
logrank,0.05116385855390369
respect,0.05115059940258251
authors,0.05114214518818357
showing,0.05110149969022018
departments,0.05109162005088662
mostly,0.051083381680268616
respond,0.05094659542465559
cardiovascular,0.05087533186948362
divided,0.050795256951052754
chromosome,0.050795256951052754
contraindication,0.05079128946690418
understand,0.05058483923224599
accordance,0.05037957350074285
foam,0.05023453222195202
contraindications,0.05012693807465439
58,0.05012693807465439
glaucoma,0.049954936447637946
fixed,0.04993151414152435
intramuscular,0.04993151414152435
vaccines,0.04992221580874448
mediated,0.04989801120297641
nevertheless,0.04989801120297641
randomizations,0.04976898736662116
arrhythmia,0.04965568044031944
brain,0.04965568044031944
1st,0.04956521512205575
autoimmunes,0.04956039509477115
immunology,0.04956039509477115
365,0.04954821819671853
38,0.049514530528818476
63,0.049398981518830855
represent,0.049397602230545144
concept,0.049397602230545144
culture,0.049397602230545144
therapeutically,0.049382992405746284
tacrolimus,0.049382992405746284
responding,0.04936909822640767
across,0.04927897382668745
intravaginal,0.04905290225247247
releasing,0.04905290225247247
inhibit,0.049030120357046056
final,0.04898791989937609
favourable,0.04893694055852889
herpes,0.048886901832253596
represents,0.04883688128055789
studied,0.04883025649156815
exchange,0.048813907778158805
marked,0.04881318786955358
peffault,0.048784192170010704
regis,0.048784192170010704
prophylactic,0.04874311530426441
pbsc,0.048705935348159424
globuline,0.048705935348159424
50ml,0.04869363503552495
exact,0.0486192368713312
colitis,0.0486140449340315
questionnaires,0.048473496667771114
75010,0.04844447764049237
applies,0.04840033108858864
suggestive,0.04828626861622036
myocardial,0.04828114709059543
infarction,0.04828114709059543
note,0.04826936670306092
spontaneous,0.04815880478968164
providing,0.048146131372681755
film,0.04812321762685889
proved,0.04812321762685889
market,0.048120814246182746
medicines,0.048120814246182746
effectiveness,0.048115539527660664
safely,0.04811228285030046
successfully,0.04811228285030046
march,0.04811228285030046
involves,0.04808772519124602
raising,0.04807803515834884
chorioretinal,0.04807803515834884
lowest,0.04795707067490707
category,0.04790588673266518
equal,0.047828303206429425
generally,0.047818655395071526
lymphoid,0.04774256089937988
220,0.047738298318956846
relation,0.04767249771627779
affiliations,0.04759914508262462
ring,0.04755365385661171
vaginal,0.04755365385661171
diaphragm,0.04755365385661171
alcohol,0.047482417979327285
united,0.04748077476545059
gut,0.04745629239170798
ulcerations,0.04745629239170798
width,0.04738432757451384
ten,0.04738432757451384
longitudinal,0.04738432757451384
aggressive,0.04715862706930961
regulation,0.04714222975710381
inserm,0.047135651797829387
ongoing,0.0471333944641007
56,0.04708871747773636
feasibility,0.04707783732820213
adding,0.04705662969416137
disappointing,0.0470504419151222
redness,0.047038497045454
fluorescein,0.04699289271520561
uveitic,0.04699289271520561
classical,0.046689788922345994
hematologic,0.0466805320965393
cmv,0.04667960623732667
sas,0.04659363902560653
luznik,0.04659363902560653
explore,0.04646127646557317
1500,0.046306956538776624
likely,0.046229093680396606
alterations,0.04613210564200426
opportunistic,0.045999260879570555
immunity,0.045999260879570555
burdens,0.045942711886684244
corresponding,0.04591063237460649
flare,0.0459089853031983
implementation,0.04585805232464761
burden,0.04582370787918327
antiviral,0.045700787792247746
upon,0.04568631962974805
approval,0.04559668646857325
heterosexual,0.04555606217623271
lancet,0.04548353719266355
reason,0.04548181697451995
positivity,0.045475590493756476
uni,0.04536428825510344
opinion,0.045345029970858895
participated,0.0453190521928101
postero,0.045303854365976344
quantiferon,0.045303854365976344
lateral,0.045303854365976344
publications,0.04528335304133388
sante,0.0452642555606348
inadequate,0.045224692416481305
failures,0.04517288633728973
04,0.045126719105355304
exists,0.04512652432477376
locally,0.0451247780298273
saes,0.0451247780298273
complex,0.04508177716489056
challenge,0.04508177716489056
favor,0.04501683401286123
bortezomib,0.04501683401286123
relapsed,0.04501683401286123
seem,0.04498957110693354
decreasing,0.04494863494240084
muscle,0.04494863494240084
44,0.04493512842711506
version,0.044933855484469355
extra,0.044905252335119786
pt,0.044872593974382924
rheumatology,0.04486827028213053
worldwide,0.04483525312181191
match,0.04483525312181191
eight,0.04480156656284391
sud,0.04478009979885672
groupe,0.04478009979885672
made,0.04470216289038019
necrosis,0.04465710243766471
ensure,0.044550124200579105
options,0.04445353056440558
gfr,0.044418875810573445
haematological,0.04435548677037922
immunologic,0.04421731285207761
sperm,0.04421731285207761
alloreactive,0.0441982186421267
empirical,0.04408831495264106
hbsag,0.044082379527205146
aom,0.044055507580458966
vasectomy,0.04397324764269909
patterns,0.04395733948875142
06,0.04393934065511647
mucositis,0.043936263079156546
encephalitis,0.04391646373684209
suppressing,0.04386355326011984
special,0.04377913354867831
seropositivity,0.04372598247917213
latour,0.04372598247917213
london,0.043713899344580316
percent,0.04364937095392401
designed,0.0435827864949363
acting,0.0435640724301965
crohn,0.04352224287262847
fistula,0.04352224287262847
code,0.04350366495914161
85,0.04334582635759742
beneficial,0.04328716409620209
remaining,0.043194003368816986
consistently,0.043184610426544284
molecule,0.043131209339180895
characteristic,0.043131209339180895
actual,0.043060603238554616
correctly,0.042996702137310626
undergo,0.04288288049139909
nocturnal,0.04287290581488455
grim,0.04287290581488455
hemoglobinuria,0.04287290581488455
provided,0.04277508309498565
paroxysmal,0.04263424816542448
spectrum,0.04263386799017639
quantification,0.04250999397536635
principle,0.04250999397536635
proliferation,0.042487700311579474
cystoid,0.04247892998705327
devastating,0.04247892998705327
administrated,0.042427704940799754
modification,0.042427704940799754
epidemiology,0.04234796335047587
osteonecrosis,0.04230382118729707
sera,0.042276469851071335
existing,0.04226413378167944
agree,0.04222719728066119
scheduled,0.04202481853279465
local,0.04201059878162475
leflunomide,0.0419815607891232
select,0.0419815607891232
terminal,0.04192544595845991
compatible,0.04192544595845991
30mg,0.04192544595845991
bio,0.04186338219152168
proof,0.04185503964551729
rarely,0.04171399976804607
set,0.04163272330952019
da,0.04156539890871483
methylprednisolone,0.04156101687779193
withdrawn,0.04156101687779193
comparatively,0.04156101687779193
checked,0.041516892976011424
calcineurin,0.041492477999645505
avenue,0.041415283074803924
marie,0.04139805803453264
immunoglobulin,0.041364496795097364
concerning,0.041364496795097364
england,0.041364496795097364
compliance,0.041364496795097364
biologically,0.04135817715029429
notably,0.04131426200373007
artery,0.041277551602865475
mechanisms,0.04126318505359874
79,0.0412542748334163
thoroughly,0.04124208008200125
ifn,0.04119247480569425
146,0.041099091970739146
principal,0.041099091970739146
altered,0.04108318509557501
irrespective,0.040882877683189565
achieves,0.04081637826641307
follows,0.040754655991148435
applied,0.0406620983562073
industrial,0.040657759450626774
attributed,0.04062693043776607
preventing,0.04058231126050657
washout,0.04051642528471995
insulin,0.04051642528471995
foxp3,0.04051642528471995
merkel,0.04051642528471995
signing,0.04051642528471995
thyroxine,0.04051642528471995
exceptions,0.04051642528471995
adrenal,0.04051642528471995
evasion,0.04051642528471995
mellitus,0.04051642528471995
implies,0.04051642528471995
vitiligo,0.04051642528471995
correlative,0.04051642528471995
axis,0.04051642528471995
physiologic,0.04051642528471995
bacillus,0.04051642528471995
histologically,0.04051642528471995
lymphedema,0.04051642528471995
cooperation,0.04051642528471995
glutamopyruvatetransferase,0.04051642528471995
pituitary,0.04051642528471995
codified,0.04051642528471995
glutamic,0.04051642528471995
oxaloacetictransferase,0.04051642528471995
undergone,0.04051642528471995
psoriasis,0.04051642528471995
modifying,0.04049233341533894
carbon,0.04029301562332896
monoxide,0.04029301562332896
underwent,0.04029228759974059
empty,0.04029228759974059
occurred,0.0402886042491685
courses,0.04028199136348422
agency,0.040154547116316185
complementary,0.04009638938899328
43,0.04008430157466451
hazard,0.040061022298892995
subset,0.0400301932860323
contra,0.04002328996967191
finger,0.04002328996967191
conduct,0.04002328996967191
investigations,0.04002328996967191
cedex,0.04002328996967191
sf36,0.040007990382315284
starting,0.03997195174453327
cytotoxicity,0.03995834681764258
naive,0.039919461689801136
rabbit,0.039735776092506614
53,0.03972934984131208
thickness,0.03968664107278503
hypotheses,0.03967442894937721
organization,0.039657177918386105
proportions,0.03965419096205049
noninfectious,0.039652838011433454
farge,0.03953030263481781
characterized,0.03941754158742844
kinetic,0.039396885533570083
findings,0.03935664858717155
thrombopenia,0.03933836880510505
inefficacy,0.03933396645140272
erythema,0.03933396645140272
epi,0.03928925050052473
ckd,0.03928925050052473
anaphylaxis,0.039246862555201156
plays,0.039173680702082075
preclude,0.039146834083389516
www,0.03911037134699108
reappearance,0.039042512616693156
ac,0.03895920302333401
drop,0.03890485702813974
throat,0.038808902635167196
nose,0.038808902635167196
paracetamol,0.03877071411366791
activation,0.03874160479389622
activated,0.03874160479389622
precludes,0.038729777949135215
software,0.03869689426903579
proportional,0.038558364288573996
reach,0.038557004798923294
2001,0.038470954200470524
process,0.03846270896450312
vivo,0.038397161731709276
overlap,0.03832174059646943
gray,0.03813445949783525
condoms,0.03795524957580144
favour,0.03788463771270915
gj,0.0377665095623262
claude,0.037750212956233424
vellefaux,0.037750212956233424
mentioned,0.03771672300510028
law,0.037689566656858825
clinic,0.0376636092277397
help,0.03762833564402459
unacceptable,0.03761505887814591
family,0.0376090018265291
percutaneous,0.03759279355544656
judgment,0.03759279355544656
ss,0.03758429727692395
rescue,0.03747520466113098
sponge,0.037407228119112956
patch,0.037407228119112956
ligation,0.037407228119112956
advance,0.03734868124485171
observation,0.03703461232700976
5n,0.03703461232700976
proposes,0.03700808596981418
appearance,0.03698399727496414
occurring,0.03694486934594915
gov,0.03688082657085919
2022,0.03664405645646929
flu,0.03658897048766204
priming,0.03654370906422007
whole,0.03638783372871674
disodium,0.0363515708215664
chi,0.0363515708215664
occlusive,0.036343922175709836
successive,0.03629927952175068
transplants,0.03628264813374078
cox,0.036270035838268336
diffusing,0.0362607980125419
suggested,0.03625847581174479
implantable,0.03625560498729183
occlusion,0.03625560498729183
vasectomised,0.03625560498729183
act,0.03625560498729183
psl,0.03624234408564585
0142178088,0.03624234408564585
never,0.0361797712690694
appendices,0.03617352472200061
documents,0.03617352472200061
notes,0.03617352472200061
envelope,0.03617352472200061
collaborator,0.03617352472200061
list,0.03617352472200061
sealed,0.03617352472200061
compensation,0.03617352472200061
together,0.03614447421543917
address,0.03608429517780342
colonic,0.03600075835763722
novel,0.03600075835763722
preliminary,0.03599573372916426
119,0.03596144181075672
comparisons,0.035951166074064816
finally,0.03592101676731334
fleming,0.03592101676731334
futility,0.03592101676731334
lan,0.03592101676731334
demets,0.03592101676731334
obrien,0.03592101676731334
beta,0.03589728613025329
thereby,0.03587388307406893
correlated,0.035853948665044835
gammaglobulin,0.035853948665044835
igg,0.035853948665044835
participant,0.03569674555189537
computation,0.03569599796621242
university,0.035692342325400125
les,0.035692342325400125
innovation,0.035692342325400125
délégation,0.035692342325400125
recombinant,0.03562528009162001
bahram,0.035597805300329945
bodaghi,0.035597805300329945
accounting,0.03553165273480503
garcia,0.03553165273480503
resting,0.035498085024030755
fai2r,0.035498085024030755
dominique,0.035498085024030755
associating,0.03544448295090488
robin,0.035364311860622846
shimoni,0.035364311860622846
castagna,0.035364311860622846
medac,0.035364311860622846
improvements,0.03523380040452193
03,0.03514746440735848
techniques,0.0350870080551199
effector,0.03507653467532572
cat,0.03503817969815472
features,0.034981575622975915
concluded,0.03492528882708572
61,0.03492287966395045
epstein,0.034902778477020585
comprehensive,0.034902778477020585
aspiration,0.034902778477020585
fact,0.034893730991513265
hospitals,0.03483587432417011
100mg,0.03483587432417011
ctae,0.03475911047103108
tubes,0.034750184657698635
validity,0.03465511387648823
cap,0.03465511387648823
implants,0.03465511387648823
131,0.03457537228616435
packed,0.03456962279407345
amenable,0.03456962279407345
dropping,0.03451266285718672
angiography,0.03432514192228013
v5,0.03431868347022395
larger,0.03431868347022395
hb,0.03413131006959735
subsequent,0.034091935046575976
otherwise,0.03400718966699082
benchmark,0.03400718966699082
randomised,0.033967620215937584
lee,0.033967620215937584
wide,0.03392733128488057
3mg,0.033917961214908754
consisted,0.03386963152953916
neuro,0.03359474974792537
nowadays,0.03359474974792537
warranted,0.03359474974792537
noted,0.03354501943818269
proteins,0.033542381621644884
mass,0.03353514652334994
interquartile,0.03351881906560998
percentages,0.03351881906560998
cytogenetic,0.03341195429671319
375,0.03323406771196801
yellow,0.03322951360702351
fully,0.03322951360702351
assay,0.03310805059610538
entire,0.03306659343272998
refraining,0.03306659343272998
guidance,0.03306659343272998
hormone,0.03306659343272998
reliability,0.03306659343272998
ctfg,0.03306659343272998
masquerade,0.03306659343272998
estrogen,0.03306659343272998
typically,0.03290124991389784
probably,0.03290124991389784
predictive,0.03290124991389784
revealed,0.03290124991389784
ensuring,0.03287316584899529
seen,0.03286386473576092
addressed,0.032862303917362196
phosphatase,0.032862303917362196
gt,0.032862303917362196
alkaline,0.032862303917362196
clinicaltrials,0.032747042835282306
myocarditis,0.032572316733759765
properly,0.032572316733759765
glucocorticoid,0.032572316733759765
excised,0.032572316733759765
signaling,0.03255657168292726
urgent,0.032545388488137116
relevant,0.032545388488137116
enhance,0.032545388488137116
pathogenesis,0.03251821121994308
reporting,0.03250571526987993
pivotal,0.0324921369976753
ideal,0.03244358664808151
measurable,0.03228799442255964
court,0.03228799442255964
posttransplantation,0.03228799442255964
spot,0.03223225951702119
latent,0.03223225951702119
igra,0.03223225951702119
transfused,0.032207349587513125
microg,0.032207349587513125
combine,0.03217317458446099
md,0.032170773109488356
le,0.031812504978740296
rule,0.03176192387295798
author,0.03173276338841641
growth,0.031729661840015654
era,0.031694477200031865
07,0.031557884184764975
reports,0.03153332565660056
physicians,0.03148797975695787
gained,0.031465867413243705
uf,0.031465867413243705
105,0.031465867413243705
critical,0.031404229458460275
importance,0.031404229458460275
attacks,0.03136769932153616
far,0.031304332028804165
108,0.031304332028804165
interview,0.031165846972284028
panel,0.031024108482739607
spending,0.03095385373810998
attractive,0.030868735226715786
nerve,0.03084263550530064
meta,0.03074712753145315
optimize,0.030689172204449014
vegf,0.030676781429814757
increasingly,0.030648959439745604
unaffected,0.03052452573614802
generated,0.03052452573614802
dividing,0.03052452573614802
cni,0.03052452573614802
leaving,0.03052452573614802
suppression,0.03052452573614802
gammaglobulines,0.03052452573614802
inhibits,0.030517922762786615
blocking,0.030517922762786615
indicate,0.030517922762786615
74,0.030358535286810016
536,0.030308908120147856
concurrent,0.0302864658594369
prostate,0.0302864658594369
contact,0.0302864658594369
calculation,0.03024890195983099
smpc,0.03024890195983099
supplementary,0.030059717435788922
functional,0.030059717435788922
accepted,0.030030556951247348
haematol,0.030030556951247348
base,0.030030556951247348
crucial,0.02976677661306672
itching,0.02973073488537628
azoospermia,0.02973073488537628
documentation,0.02973073488537628
increasing,0.02949827446575333
ms,0.02943517836557939
answer,0.029400088060008878
beelen,0.029330565686713057
controlling,0.029172278281637626
inactivity,0.029172278281637626
authorized,0.02913787154293518
http,0.028903513628317425
87,0.0288140600226617
member,0.028637659748119347
natural,0.028467431105167612
monocular,0.02841276411775201
study,0.02841276411775201
alkylating,0.02841276411775201
chlorambucil,0.02841276411775201
8g,0.02841276411775201
supporting,0.028352398559077667
causes,0.028029187092094277
cy,0.02793387404202779
rm,0.02793387404202779
crohns,0.02780944785249482
ulceration,0.027711279760787272
uveites,0.027631538170463384
00,0.027600303623423156
regional,0.02749485100849066
plan,0.02749485100849066
7mg,0.02749485100849066
covariate,0.02746756710405211
interactions,0.02746756710405211
carefully,0.02746756710405211
essentially,0.02746756710405211
obviously,0.02746756710405211
realization,0.02746756710405211
congestive,0.02743364980245665
optional,0.02743364980245665
degree,0.02743364980245665
2nd,0.02743364980245665
benign,0.02743364980245665
way,0.02743364980245665
necessitating,0.02743364980245665
1h,0.02743364980245665
pulse,0.02743364980245665
monocentric,0.02743364980245665
36v2,0.02743364980245665
vary,0.02743364980245665
3rd,0.02743364980245665
sign,0.02743364980245665
similarly,0.02743364980245665
myelodysplasia,0.02743364980245665
produced,0.02743364980245665
indications,0.02738554368477741
grant,0.027095708859191887
org,0.027095708859191887
https,0.027095708859191887
481,0.027095708859191887
hand,0.027053769409433465
mouse,0.02700675407792868
against,0.02695998991071348
survey,0.02695998991071348
presentation,0.02695998991071348
104,0.0267149099206661
immediately,0.0267149099206661
guarantees,0.026546395727320156
ophthalmologic,0.026546395727320156
nature,0.026546395727320156
contrasting,0.026546395727320156
162mg,0.026546395727320156
immunosuppressors,0.026546395727320156
selecting,0.026546395727320156
modulate,0.026358829868431265
kaplan,0.026353778144899177
karyotype,0.026353778144899177
meier,0.026353778144899177
boundaries,0.026088381247014923
39,0.026067505651595935
details,0.026027499825001868
zero,0.02592933173329432
blockers,0.02592933173329432
sustain,0.02592933173329432
autoinflammatoires,0.02576516978003153
juvenile,0.02576516978003153
limiting,0.02569901721450662
fast,0.02569901721450662
nguyen,0.02569901721450662
br,0.02569901721450662
call,0.02569901721450662
med,0.02569901721450662
propensity,0.025697262996651385
naturally,0.025697262996651385
reactants,0.025628482618058807
antiinflammatory,0.025628482618058807
depends,0.025628482618058807
icbd,0.025628482618058807
irreversible,0.025628482618058807
nonsteroidal,0.025628482618058807
advocated,0.025628482618058807
guided,0.025628482618058807
paraclinical,0.025628482618058807
75013,0.025628482618058807
etanercept,0.025628482618058807
colchicine,0.025628482618058807
lhopital,0.025628482618058807
urgently,0.02546603854092937
associations,0.02546603854092937
assigned,0.025346450532722213
randomly,0.025346450532722213
contrast,0.02502323906573882
expansion,0.024891590530794303
mfi,0.024691496202873142
historic,0.024691496202873142
hopkins,0.024691496202873142
diphenhydramine,0.024691496202873142
haplotype,0.024691496202873142
coronary,0.024691496202873142
john,0.024691496202873142
uk,0.024691496202873142
cgvhd,0.024691496202873142
geno,0.024691496202873142
allograft,0.024691496202873142
antihistaminic,0.024691496202873142
engrafted,0.024691496202873142
pyretic,0.024691496202873142
150mg,0.024691496202873142
morphologic,0.024691496202873142
nationwide,0.024691496202873142
cytolysis,0.024691496202873142
kings,0.024691496202873142
neutrophiles,0.024691496202873142
impairment,0.02457282532051224
conjugate,0.02457282532051224
mononuclear,0.0242151557859212
randomize,0.023996810777337556
martin,0.023996810777337556
collected,0.023925025956410065
surgical,0.023777230241707765
250,0.023777230241707765
increases,0.02369596166210204
towards,0.023665226618441546
retrospectively,0.023665226618441546
se,0.023571114878551905
mouth,0.023567058526734
covering,0.023359672974676827
april,0.023359672974676827
begin,0.023352881842075807
identifying,0.023352881842075807
89,0.0233297075051101
blast,0.023296819512803265
cibmtr,0.023296819512803265
sakellari,0.023296819512803265
nc,0.023296819512803265
appear,0.022974536467141628
exceptionally,0.02287636837543408
revised,0.022640304364555476
nathalie,0.022640304364555476
interaction,0.02232661225764421
mechanism,0.02232661225764421
expect,0.0222894919006263
explored,0.0222894919006263
unknown,0.0222894919006263
zhou,0.0222894919006263
painful,0.022228444165936664
settings,0.022228444165936664
001,0.02221362722279846
consensus,0.02213345613251643
example,0.021995282214214817
86,0.021995282214214817
g1,0.021995282214214817
theoretical,0.021995282214214817
h2,0.021995282214214817
balance,0.021995282214214817
indirect,0.021995282214214817
dc,0.021929288352659573
interne,0.021929288352659573
112,0.021929288352659573
medecine,0.021929288352659573
clin,0.021900127868118
mj,0.021900127868118
jh,0.021900127868118
immunol,0.021900127868118
damages,0.021751832479570805
1121,0.021751832479570805
enhancement,0.021694433098979303
updated,0.021694433098979303
disappearance,0.021694433098979303
gadolinium,0.021694433098979303
83,0.021694433098979303
analyzing,0.021634537570777233
130,0.021295290949680527
judgement,0.021295290949680527
familial,0.021295290949680527
essential,0.021295290949680527
analyze,0.021295290949680527
guarantee,0.021295290949680527
sfgm,0.02115819715382529
posttransplant,0.02115819715382529
tc,0.02115819715382529
agvhd,0.02115819715382529
jean,0.020638775801432738
ischemic,0.020638775801432738
46,0.020295923209979895
modulation,0.020295923209979895
analysed,0.020287963337503562
display,0.020287963337503562
produce,0.02006291996222772
untreated,0.019964751870520173
ulcers,0.019964751870520173
rhythm,0.019633009007654495
69,0.019633009007654495
93,0.019633009007654495
justified,0.019633009007654495
behaviour,0.018942318856354574
conclusions,0.018942318856354574
improving,0.018942318856354574
treating,0.018294394646857157
84,0.018294394646857157
transformation,0.018294394646857157
suggests,0.018294394646857157
pathways,0.018294394646857157
waiting,0.018294394646857157
macrophages,0.018294394646857157
subsets,0.018294394646857157
chinese,0.01813039900627095
council,0.018086762361000305
correspondence,0.018086762361000305
accompanied,0.018086762361000305
manner,0.018086762361000305
understandable,0.018086762361000305
prove,0.018086762361000305
fault,0.018086762361000305
insure,0.018086762361000305
71,0.018086762361000305
exhaustive,0.018086762361000305
archiving,0.018086762361000305
archived,0.018086762361000305
decisions,0.018086762361000305
includes,0.018086762361000305
indexed,0.018086762361000305
ethics,0.018086762361000305
n536,0.018086762361000305
covers,0.018086762361000305
linnovation,0.018086762361000305
laypersons,0.018086762361000305
staff,0.018086762361000305
register,0.018086762361000305
registration,0.018086762361000305
refused,0.018086762361000305
direction,0.018086762361000305
consented,0.018086762361000305
hdi,0.018086762361000305
authorisations,0.018086762361000305
ctis,0.018086762361000305
voluntary,0.018086762361000305
submit,0.018086762361000305
versions,0.018086762361000305
beneficiaries,0.018086762361000305
grounds,0.018086762361000305
binders,0.018086762361000305
policy,0.018086762361000305
biomedic,0.018086762361000305
parliament,0.018086762361000305
sponsors,0.018086762361000305
broker,0.018086762361000305
competent,0.018086762361000305
111,0.01789707074187252
ministere,0.017798902650164972
lost,0.017798902650164972
2006,0.017798902650164972
plasmatic,0.017798902650164972
scanner,0.017798902650164972
proposing,0.01715514002757981
recommend,0.01715514002757981
situations,0.017056971935872262
achieved,0.017056971935872262
furthermore,0.01609970995860664
slower,0.01609970995860664
soluble,0.016030702351440666
framework,0.016030702351440666
city,0.015866381694208204
website,0.015866381694208204
ja,0.015866381694208204
name,0.015866381694208204
naming,0.015866381694208204
institution,0.015866381694208204
institutions,0.015866381694208204
1055,0.015866381694208204
140,0.015866381694208204
rao,0.015866381694208204
unimportant,0.015866381694208204
engl,0.015866381694208204
comparative,0.015866381694208204
hogan,0.015866381694208204
tender,0.015866381694208204
postcode,0.015866381694208204
funders,0.015866381694208204
semicolon,0.015866381694208204
separated,0.015866381694208204
ca,0.015866381694208204
governing,0.015866381694208204
592,0.015866381694208204
relating,0.015866381694208204
sm,0.015866381694208204
front,0.015866381694208204
feature,0.015866381694208204
jp,0.015866381694208204
add,0.015866381694208204
possibility,0.015124450979915495
013,0.015124450979915495
3n,0.015124450979915495
multivariate,0.015124450979915495
641,0.015124450979915495
aid,0.015124450979915495
102,0.014098181395483899
121,0.014098181395483899
rather,0.014000013303776352
induces,0.014000013303776352
ya,0.014000013303776352
auxiliary,0.014000013303776352
immunologie,0.013864853131085465
meaningful,0.013122922416792755
carry,0.013122922416792755
expertise,0.013122922416792755
73,0.013122922416792755
external,0.013122922416792755
marker,0.011998484740653612
monocytes,0.011998484740653612
class,0.011998484740653612
signal,0.011998484740653612
distribution,0.011998484740653612
2024,0.011998484740653612
129,0.010065963784696846
depend,0.010065963784696846
origin,0.010065963784696846
partially,0.010065963784696846
supported,0.010065963784696846
117,0.010065963784696846
flow,0.010065963784696846
cytometry,0.010065963784696846
memory,0.010065963784696846
